In Brief: Copley Pharmaceutical
This article was originally published in The Tan Sheet
Executive Summary
Copley Pharmaceutical: Will launch its generic minoxidil 2% by mid-June, following FDA's May 23 approval of the company's ANDA, Copley says. The product will be sold as Minoxidil Topical Solution 2% for Men Hair Regrowth Treatment in a box featuring a graphic of a balding head. The suggested retail price is expected to be $12-15 per box of two 60 ml bottles. Copley trails Bausch & Lomb, Teva and Alpharma, which began shipping their private label versions of Pharmacia & Upjohn's OTC Rogaine in early May ("The Tan Sheet" May 6, p. 5)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning